NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Soft Tissue Sarcoma Subtype · UPS / MFH · NABH Accredited

Undifferentiated Pleomorphic Sarcoma (UPS / MFH)

Undifferentiated pleomorphic sarcoma — UPS, the diagnosis formerly known as malignant fibrous histiocytoma (MFH) — is one of the most common high-grade soft tissue sarcomas in adults. It is called "undifferentiated" because, under the microscope, the cancer cells have lost every clue to the normal tissue they came from, and "pleomorphic" because those cells vary wildly in size and shape. If you or a family member has just been handed a report with these words, this page explains in plain language what UPS sarcoma is, how it is diagnosed and graded, how it behaves, and how CION's sarcoma team treats it across 7 NABH-accredited Hyderabad locations.

  • A diagnosis of exclusion — confirmed only after immunohistochemistry rules out every other pleomorphic tumour
  • Usually high-grade — fast-growing, most often in the deep thigh, buttock, or upper arm of adults over 50
  • Treated chiefly by surgery + radiation — wide local excision to a clear margin, usually with radiotherapy
  • Lungs are the site to watch — staging always includes a CT scan of the chest
4.8 · 1,000+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get Your UPS / MFH Report Reviewed

₹950   Today: FREE  ·  Including free written second opinion

Biopsy & immunohistochemistry re-read by sarcoma specialist
Surgery + radiation plan reviewed by tumour board
Confidential. No commitment to start treatment.
or
Call 18002028726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

What Is Undifferentiated Pleomorphic Sarcoma?

Undifferentiated pleomorphic sarcoma (UPS) is a high-grade cancer of the body's soft tissues — the muscle, fat, and supporting connective tissue beneath the skin. The name is a precise description of what the pathologist sees: the cells are undifferentiated, meaning they have lost all the microscopic features that would link them to a recognisable parent tissue such as fat, muscle, or nerve; and they are pleomorphic, meaning they vary dramatically in size and shape, with large, ugly, abnormally dividing nuclei. In other words, UPS is the sarcoma that "looks like nothing else" because it no longer resembles any normal tissue at all.

You may also see this tumour called malignant fibrous histiocytoma (MFH). For decades MFH was thought to be the single most common adult soft tissue sarcoma. As immunohistochemistry and molecular testing improved, pathologists realised that many tumours once labelled MFH were in fact other sarcomas that had simply de-differentiated and lost their identity. The World Health Organization therefore retired "malignant fibrous histiocytoma" and reclassified the genuinely line-less tumours as undifferentiated pleomorphic sarcoma. So UPS and MFH refer to the same clinical entity — UPS is simply the modern, more accurate name, and an older report saying "MFH" is describing this same disease.

UPS is part of the broad family of soft tissue sarcomas. To see where it sits among the other subtypes and how sarcoma is approached in general, our sarcoma — overview hub sets out the full picture, and the dedicated sarcoma treatment in Hyderabad page explains how diagnosis and care are organised locally.

Did You Know? "Undifferentiated" is not a measure of how dangerous a tumour is on its own — it describes how unrecognisable the cells have become. But because losing all differentiation usually goes hand in hand with aggressive behaviour, almost every UPS is reported as high-grade. That is why your pathology report will often read "undifferentiated high-grade pleomorphic sarcoma" — the two words travel together.

Who Gets UPS, and Where Does It Appear?

Undifferentiated pleomorphic sarcoma is mainly a disease of older adults, with most cases diagnosed after the age of 50 and a slight predominance in men. It is rare in children and young adults. There is usually no identifiable cause, although a small number of cases arise years after radiation therapy given for a previous cancer in the same region — a so-called radiation-associated sarcoma.

The most common location is deep within the large muscles of the thigh, buttock, or upper arm. Because it grows in the deep tissue rather than just under the skin, a UPS often reaches a substantial size before it is noticed. It can also arise in the trunk and, less commonly, in the retroperitoneum — the deep space at the back of the abdomen — where it may grow very large before causing symptoms.

The classic presentation is a firm, deep, rapidly enlarging lump that is often surprisingly painless for its size. Pain, when present, usually comes from the mass pressing on a nerve or stretching surrounding tissue. Any deep soft tissue lump that is larger than a golf ball (about 5 cm), is growing, or is fixed to the underlying muscle deserves an urgent specialist opinion rather than reassurance — the single most important step is to get the right imaging and biopsy before anyone attempts to remove it.

Why the lump should be imaged and biopsied first: a UPS that is "shelled out" as if it were a harmless lipoma almost always leaves cancer behind and contaminates the surrounding tissue. The correct sequence is MRI, then a planned core needle biopsy, and only then surgery — read more about why surgeons insist on wide local excision & clear margins explained before any tumour is removed.

Worried About a Deep, Growing Lump?

Send us your MRI and biopsy report. Our sarcoma team will tell you honestly whether it points to UPS, what grade and stage it suggests, and what the right next step is. Free written second opinion included.

or
Call 18002028726

By submitting, you consent to be contacted by CION about your enquiry.

12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a Clear Plan for UPS / MFH

Whether you have just been diagnosed with undifferentiated pleomorphic sarcoma or are weighing a surgery-and-radiation plan, our multidisciplinary team will tell you exactly what your grade and stage mean — and map your treatment across 7 Hyderabad locations with same-week appointments.

How UPS Is Diagnosed, Graded, and Staged

Because undifferentiated pleomorphic sarcoma is a diagnosis of exclusion, getting it right depends on a careful, ordered workup rather than a single test. Each step answers a different question — what is it, how aggressive is it, and how far has it spread.

Step 1 — MRI of the Primary Site

MRI is the imaging investigation of choice for any deep soft tissue mass. For a suspected UPS it shows the tumour's true size, its depth, and its exact relationship to muscle compartments, the major blood vessels, nerves, and bone. This map is what the surgeon later uses to plan a clear margin and to decide whether the limb can be preserved. MRI cannot, on its own, prove the tumour is a UPS — but it is essential before any biopsy or surgery.

Step 2 — Core Needle Biopsy With Immunohistochemistry

A core needle biopsy takes a thin cylinder of tumour for the pathologist. For UPS this step is decisive, because the diagnosis is only made after a panel of immunohistochemistry (IHC) stains has ruled out other pleomorphic tumours — a de-differentiated liposarcoma, a pleomorphic leiomyosarcoma, a pleomorphic rhabdomyosarcoma, a melanoma, or even a sarcomatoid carcinoma. Only when no specific line of differentiation can be demonstrated is the tumour labelled "undifferentiated." This is why a UPS diagnosis should always be confirmed by a pathologist experienced in sarcoma, and why CION re-reads outside slides as part of every second opinion.

Step 3 — Grading the Tumour

Grade describes how aggressive the cancer looks and is the strongest predictor of whether it will spread. Sarcoma grade is scored on three features — how much the cells resemble normal tissue (differentiation), how many cells are actively dividing (mitotic count), and how much dead tissue is present (necrosis) — usually combined into the FNCLCC grade. UPS is, by its nature, almost always grade 2 or grade 3 (high-grade).

Step 4 — Staging With a Chest CT

Undifferentiated pleomorphic sarcoma spreads through the bloodstream, and its favourite destination is the lungs. For that reason a CT scan of the chest is part of the standard staging for every UPS, alongside the MRI of the primary site. Stage combines the tumour's size, its depth, its grade, and whether it has reached the lymph nodes or distant organs — and it is the foundation for the whole treatment plan.

Did You Know? Unlike many carcinomas, undifferentiated pleomorphic sarcoma rarely spreads to the lymph nodes — it travels through the blood to the lungs instead. That is why staging for UPS centres on a CT of the chest rather than on a search for swollen glands, and why a normal lymph node examination should never be taken as reassurance that the disease has not moved.

How CION Treats UPS Sarcoma — Surgery, Radiation, and Beyond

Treatment for undifferentiated pleomorphic sarcoma is planned at CION's multidisciplinary tumour board, where the surgeon, radiation oncologist, medical oncologist, radiologist, and pathologist agree a single plan before anything begins. For a localised UPS in a limb, that plan almost always combines surgery with radiotherapy.

Surgery — Wide Local Excision to a Clear Margin

The backbone of curative treatment is wide local excision: removing the tumour together with a cuff of surrounding normal tissue so that no cancer reaches the cut edge (an R0, margin-negative resection). Margin status is the single strongest surgical predictor of whether the cancer comes back locally. For limb UPS this is performed as limb-sparing surgery wherever possible — the full mechanics of margins and why the first operation matters are explained in our guide to wide local excision & clear margins explained.

Radiotherapy — Before or After Surgery

Because UPS is high-grade and often large, radiotherapy is usually combined with surgery to control any microscopic disease the knife cannot reach. It may be given before surgery (neoadjuvant) to shrink the tumour and protect a tight margin, or after surgery (adjuvant) to the surgical bed. Modern techniques such as IMRT, IGRT, and in selected cases IORT focus the dose on the tumour while sparing healthy tissue — read more in our overview of radiation therapy for sarcoma (IMRT / IGRT / IORT).

Chemotherapy — For High-Risk and Metastatic Disease

Chemotherapy is not used for every UPS. It is considered for large, high-grade tumours at greater risk of spreading, and is the mainstay when the disease has already reached the lungs. Anthracycline-based regimens (such as doxorubicin, often with ifosfamide) are the usual first choice. The decision is individualised at the tumour board, weighing the tumour's grade and size against the patient's age and fitness.

Prognosis — What the Numbers Mean

Outlook in UPS depends most on grade, size, depth, and whether a clear surgical margin was achieved. A small, completely excised tumour caught before it spreads has a far better outlook than a large, high-grade tumour or one already in the lungs. Because most UPS is high-grade, lifelong surveillance — repeat MRI of the primary site and CT of the chest — is part of care, since both local recurrence and lung spread can appear in the first few years. The single biggest lever on outcome remains a correct first treatment: the right biopsy, a clear margin, and appropriate radiation, all planned together from the start.

Send Us Your UPS Report for a Free Review

Upload your MRI, biopsy result, and immunohistochemistry report. Our tumour board will confirm the grade and stage, and tell you whether surgery, radiation, chemotherapy — or a combination — is the right plan, and what it would cost.

or
Call 18002028726

Indicative Cost of UPS Diagnosis & Treatment in Hyderabad

Costs vary with the tumour's size, depth, the type of surgery and reconstruction needed, and the radiation and chemotherapy plan. The figures below are indicative ranges for the individual components of UPS care in Hyderabad and are not a substitute for a personalised estimate.

Procedure / InvestigationApprox. Cost (INR)Notes
MRI (primary site, soft tissue protocol)₹6,000 – ₹20,000Essential before biopsy or surgery
Core Needle Biopsy + IHC panel₹10,000 – ₹30,000Immunohistochemistry needed to confirm UPS
CT Chest (staging for lung spread)₹4,000 – ₹9,000Standard staging for every UPS
Wide Local Excision (limb UPS)₹1,50,000 – ₹5,00,000Varies by size, depth, and reconstruction
Radiotherapy (IMRT/IGRT, neoadj. or adj.)₹1,20,000 – ₹2,50,000Combined with surgery for high-grade disease

Costs are indicative. A personalised estimate is provided after your CION consultation. EMI options and cashless support through major TPAs, Aarogyasri, CGHS, ECHS & ESI are available for eligible patients.

Why Patients Choose CION for UPS / MFH Sarcoma Care

A correct first diagnosis and a single, coordinated plan matter more in UPS than almost any other cancer. Here is why patients trust CION.

AIIMS-trained surgical oncologist

Dr. Muralidhar Muddusetty — wide local excision & limb-sparing surgery for UPS

Specialist sarcoma pathology & IHC re-read

Outside slides reviewed; immunohistochemistry confirms UPS vs mimics

Tumour board before every treatment

Surgery, radiation, medical oncology & pathology agree one plan

Modern radiotherapy on site

IMRT / IGRT, neoadjuvant or adjuvant, to protect a clear margin

Limb-sparing wherever possible

Amputation avoided in the great majority of limb sarcomas

Medical oncology for high-risk disease

Anthracycline-based chemotherapy when grade, size or spread demand it

7 NABH-accredited Hyderabad locations

Kukatpally, Kompally, Ameerpet, Tolichowki, MasabTank, L.B. Nagar, Banjara Hills

EMI facility & insurance accepted

All major TPAs · Aarogyasri, CGHS, ECHS & ESI for eligible patients

4.8 / 5 Google rating

Across 1,000+ patient reviews

Take The Next Step

Talk to a Sarcoma Specialist About UPS

A correct diagnosis, a clear surgical margin, and the right radiation plan — decided together from the start — give the best chance against undifferentiated pleomorphic sarcoma. If you have a report or a growing lump, talk to us first.

Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Undifferentiated Pleomorphic Sarcoma (UPS / MFH) — Frequently Asked Questions

Is undifferentiated pleomorphic sarcoma the same as malignant fibrous histiocytoma (MFH)?

Yes — they refer to the same clinical disease. "Malignant fibrous histiocytoma" was the older name, used for decades for high-grade pleomorphic sarcomas. As immunohistochemistry and molecular testing improved, pathologists found that many tumours once called MFH were actually other sarcomas that had de-differentiated, so the World Health Organization retired the term and renamed the genuinely line-less tumours "undifferentiated pleomorphic sarcoma" (UPS). If your report says MFH, it is describing the same condition; UPS is simply the modern, more accurate label.

Why is UPS called a "diagnosis of exclusion"?

Because UPS is defined by what it is NOT. The pathologist can only call a tumour "undifferentiated" after a panel of immunohistochemistry stains has ruled out every tumour that does show a recognisable line of differentiation — such as de-differentiated liposarcoma, pleomorphic leiomyosarcoma, pleomorphic rhabdomyosarcoma, melanoma, or a sarcomatoid carcinoma. Only when no specific origin can be demonstrated is the diagnosis UPS. This is why a UPS report should always be confirmed by a sarcoma-experienced pathologist, and why CION re-reads outside slides during a second opinion.

Is UPS always high-grade, and where does it usually spread?

Almost always. By its nature an undifferentiated tumour behaves aggressively, so the great majority of UPS cases are reported as grade 2 or grade 3 (high-grade) on the FNCLCC system — your report will often read "undifferentiated high-grade pleomorphic sarcoma." When it spreads, UPS travels through the bloodstream and most often reaches the lungs; it rarely involves the lymph nodes. That is why staging always includes a CT scan of the chest, and why lung surveillance continues for years after treatment.

How is UPS sarcoma treated?

Localised UPS is treated chiefly with surgery and radiation. The cornerstone is a wide local excision to a clear (R0) margin — removing the tumour with a cuff of normal tissue, usually as limb-sparing surgery. Because UPS is high-grade and often large, radiotherapy (IMRT/IGRT) is generally combined with surgery, given either before to shrink the tumour and protect a tight margin, or after to the surgical bed. Chemotherapy is added for large, high-grade, or metastatic disease. At CION the whole plan is agreed by a multidisciplinary tumour board before treatment begins.

What is the outlook for someone with UPS?

Prognosis depends most on the tumour's grade, size, depth, and whether a clear surgical margin was achieved. A small tumour removed completely before it has spread has a much better outlook than a large, high-grade tumour or one that has already reached the lungs. Because most UPS is high-grade, lifelong surveillance with repeat MRI of the primary site and CT of the chest is part of care, as both local recurrence and lung metastases can appear in the early years. The strongest lever on outcome is a correct first treatment — the right biopsy, a clear margin, and appropriate radiation, all planned together from the start.

Explore more

Explore All Sarcoma Topics

Browse our complete library of sarcoma guides — covering lumps and early signs, diagnosis and biopsy, soft tissue and bone subtypes, GIST, treatment, genetics, survival, survivorship, and cost in Hyderabad.

Call now Book free consultation